Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Krystal Biotech, Inc. (KRYS)
USD363.44
-2.37 (-0.65%)
US NASDAQ Healthcare Biotechnology
Address
2100 Wharton Street 15203
Pittsburgh, PA, US
Pittsburgh, PA, US
CEO
Krish S. Krishnan
Website
krystalbio.com
IPO
2017-09-20
CIK 1711279 ISIN US5011471027
Description
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising programs: KB105 is in Phase I/II clinical trials for patients suffering from deficient autosomal recessive congenital ichthyosis; KB301 is also in Phase I/II development, aiming to ameliorate wrinkles and other signs of aging or damaged skin. Additionally, Krystal Biotech is conducting preclinical research on KB407 for cystic fibrosis and KB104 for Netherton syndrome. In its earlier discovery phase, the company is exploring candidates such as KB5xx for chronic skin conditions and multiple KB3xx programs targeting aesthetic dermatological concerns. Krystal Biotech, Inc. was established in 2015 and is based in Pittsburgh, Pennsylvania.
News Sentiment (7d)
Based on only 1 article — low confidence
- 3 Soaring Stocks That May Have More Upside Ahead Fool - Investing News
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD363.44
-2.37 (-0.65%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
313.1K
Beta
0.53
Float Shares
23.16M
Free Float %
78.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.35% | +8.27% | +20.80% | +15.77% | +54.11% | +26.91% | +124.40% | +254.90% | +398.93% | +2,840.60% | +2,840.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (17 ratings, all time)
Buy
Price Targets & DCF
Current price
363.44
Low
300.00
-17.5%
Consensus
326.20
-10.2%
Median
323.00
-11.1%
High
371.00
+2.1%
DCF (Unlevered)
573.07
+57.7%
DCF (Levered)
372.14
+2.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
91% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 10 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
300.00
-17.5%
|
| Last Quarter | 3 |
331.33
-8.8%
|
| Last Year | 7 |
295.86
-18.6%
|
| All Time | 13 |
243.77
-32.9%
|
Quality scores
Altman Z-Score
46.56
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✓ MOAT relativo
-
Revenue growth Biotechnology: +1.6%+33.9% ★ Q1'26: +31.9% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+128.0% ★ Q1'26: +52.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+36.0% ★ Q1'26: +62.9% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+41.5% ★ Q1'26: +46.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+40.2% ★ Q1'26: +43.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+0.7% ★ Q1'26: +2.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.06× ★ Q1'26: 0.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 8 EPS Ana. |
Dec 2027 6 Rev. Ana. 7 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
Dec 2029 5 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
50.70M
est: 166.23M (-69.5%)
|
290.52M
est: 289.95M (+0.2%)
|
389.13M
est: 387.65M (+0.4%)
|
522.14M
482.13M – 587.34M
+34.7% YoY
|
659.57M
644.01M – 675.12M
+26.3% YoY
|
847.87M
832.62M – 863.12M
+28.5% YoY
|
1.33B
1.26B – 1.42B
+57.0% YoY
|
1.73B
1.64B – 1.84B
+29.7% YoY
|
| EBITDA |
-91.32M
est: 60.17M (-251.8%)
|
109.91M
est: 104.94M (+4.7%)
|
167.85M
est: 140.30M (+19.6%)
|
188.98M
174.50M – 212.58M
+34.7% YoY
|
238.72M
233.09M – 244.35M
+26.3% YoY
|
306.87M
301.35M – 312.39M
+28.5% YoY
|
481.71M
456.11M – 513.51M
+57.0% YoY
|
624.98M
591.76M – 666.25M
+29.7% YoY
|
| EBIT |
-97.23M
est: 58.84M (-265.2%)
|
103.20M
est: 102.63M (+0.6%)
|
161.30M
est: 137.20M (+17.6%)
|
184.81M
170.65M – 207.88M
+34.7% YoY
|
233.45M
227.94M – 238.96M
+26.3% YoY
|
300.10M
294.70M – 305.50M
+28.5% YoY
|
471.08M
446.04M – 502.18M
+57.0% YoY
|
611.19M
578.70M – 651.54M
+29.7% YoY
|
| Net Income |
10.93M
est: 105.94M (-89.7%)
|
89.16M
est: 81.83M (+9.0%)
|
204.83M
est: 203.23M (+0.8%)
|
236.53M
185.80M – 286.93M
+16.4% YoY
|
308.75M
174.05M – 450.27M
+30.5% YoY
|
462.52M
209.85M – 632.30M
+49.8% YoY
|
754.47M
702.33M – 819.22M
+63.1% YoY
|
1.04B
971.44M – 1.13B
+38.3% YoY
|
| SGA |
98.40M
est: 156.57M (-37.2%)
|
113.69M
est: 273.09M (-58.4%)
|
146.74M
est: 365.11M (-59.8%)
|
491.79M
454.10M – 553.19M
+34.7% YoY
|
621.22M
606.57M – 635.87M
+26.3% YoY
|
798.58M
784.22M – 812.94M
+28.5% YoY
|
1.25B
1.19B – 1.34B
+57.0% YoY
|
1.63B
1.54B – 1.73B
+29.7% YoY
|
| EPS |
0.40
est: 3.75 (-89.3%)
|
3.12
est: 2.76 (+13.2%)
|
7.08
est: 6.75 (+4.9%)
|
7.75
6.20 – 9.58
+14.8% YoY
|
9.71
5.81 – 15.03
+25.3% YoY
|
12.76
7.01 – 21.11
+31.4% YoY
|
25.19
23.45 – 27.35
+97.4% YoY
|
34.84
32.43 – 37.83
+38.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-05 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-05-04 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 4/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
300.35M
OE per share TTM
10.06
Owner's Yield
3.28%
Maintenance CapEx ratio
30.94%
Maint CapEx / Avg PPE
113.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
65
Total invested
88.49M
Insider transactions (90d)
0
Beneficial owners (>5%)
33
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group - 23-1945930 | 2.44M | 8.64% | — | 39.3K | 2.37M | 62.0K | IA | Pennsylvania | 2024-02-13 | ↗ |
| 2 | Krish S. Krishnan | 2.15M | 14.90% | 2.04M | 112.2K | 2.04M | 112.2K | IN | U.S.A. | 2019-02-19 | ↗ |
| 3 | Suma M. Krishnan | 2.11M | 14.60% | 2.00M | 112.2K | 2.00M | 112.2K | IN | U.S.A. | 2019-02-19 | ↗ |
| 4 | 12.1%(2) | 2.10M | 12.10% | 1.99M | 112.2K | 1.99M | 112.2K | IN | U.S.A. | 2020-02-14 | ↗ |
| 5 | Steven A. Cohen | 1.86M | 4.00% | — | 1.86M | — | 1.86M | IN | Citizenship or place of organization United States | 2022-02-14 | ↗ |
| 6 | Point72 Asset Management, L.P. | 1.86M | 4.00% | — | 1.86M | — | 1.86M | PN | Citizenship or place of organization Delaware | 2022-02-14 | ↗ |
| 7 | Point72 Capital Advisors, Inc. | 1.86M | 4.00% | — | 1.86M | — | 1.86M | CO | Citizenship or place of organization Delaware | 2022-02-14 | ↗ |
| 8 | Jeremy C. Green | 1.68M | 8.50% | — | 1.68M | — | — | HC, IN | Delaware | 2021-02-16 | ↗ |
| 9 | Redmile Group, LLC | 1.68M | 8.50% | — | 1.68M | — | — | IA, OO | Delaware | 2021-02-16 | ↗ |
| 10 | (1) BlackRock, Inc. | 1.61M | 6.40% | 1.57M | — | 1.61M | — | HC | Delaware | 2022-02-03 | ↗ |
| 11 | STATE STREET CORPORATION | 1.45M | 5.10% | — | 1.38M | — | — | HC | MA | 2024-10-16 | ↗ |
| 12 | Avoro Capital Advisors LLC | 1.41M | 5.50% | 1.41M | — | 1.41M | — | IA, OO | Delaware | 2023-02-14 | ↗ |
| 13 | Behzad Aghazadeh | 1.41M | 5.50% | 1.41M | — | 1.41M | — | IN | United States | 2023-02-14 | ↗ |
| 14 | Abigail P. Johnson | 1.15M | 6.63% | — | — | 1.15M | — | IN | Delaware | 2020-02-07 | ↗ |
| 15 | FMR LLC | 1.15M | 6.63% | — | — | 1.15M | — | HC | Delaware | 2020-02-07 | ↗ |
| 16 | Select Biotechnology Portfolio | 1.15M | 6.63% | 1.15M | — | — | — | IV | Delaware | 2020-02-07 | ↗ |
| 17 | OrbiMed Capital LLC | 933.5K | 5.39% | — | 933.5K | — | — | IA | Delaware | 2020-02-14 | ↗ |
| 18 | Dilip S. Shanghvi | 914.1K | 4.10% | — | 914.1K | — | 914.1K | HC, IN | The Netherlands | 2021-03-09 | ↗ |
| 19 | Sun Pharma (Netherlands) B.V. | 914.1K | 4.10% | — | 914.1K | — | 914.1K | CO | The Netherlands | 2021-03-09 | ↗ |
| 20 | Sun Pharmaceutical Industries Limited | 914.1K | 4.10% | — | 914.1K | — | 914.1K | HC, CO | The Netherlands | 2021-03-09 | ↗ |
| 21 | 5.2% (2) | 895.0K | 5.20% | — | 895.0K | — | 895.0K | OO | — | 2020-02-13 | ↗ |
| 22 | FHMLS IX, L.L.C. | 895.0K | 4.50% | — | 895.0K | — | 895.0K | OO | Delaware | 2021-02-04 | ↗ |
| 23 | FHMLS IX, L.P. | 895.0K | 4.50% | — | 895.0K | — | 895.0K | PN | Delaware | 2021-02-04 | ↗ |
| 24 | Frazier Life Sciences IX, L.P. | 895.0K | 4.50% | — | 895.0K | — | 895.0K | PN | Delaware | 2021-02-04 | ↗ |
| 25 | James Topper | 895.0K | 4.50% | — | 895.0K | — | 895.0K | IN | Delaware | 2021-02-04 | ↗ |
| 26 | Patrick Heron | 895.0K | 4.50% | — | 895.0K | — | 895.0K | IN | Delaware | 2021-02-04 | ↗ |
| 27 | Baker Bros. Advisors (GP) LLC | 698.9K | 3.50% | 698.9K | — | 698.9K | — | HC, OO | OR PLACE OF ORGANIZATION | 2021-02-16 | ↗ |
| 28 | Baker Bros. Advisors LP | 698.9K | 3.50% | 698.9K | — | 698.9K | — | IA, PN | OR PLACE OF ORGANIZATION | 2021-02-16 | ↗ |
| 29 | Felix J. Baker | 698.9K | 3.50% | 698.9K | — | 698.9K | — | HC, IN | OR PLACE OF ORGANIZATION | 2021-02-16 | ↗ |
| 30 | Julian C. Baker | 698.9K | 3.50% | 698.9K | — | 698.9K | — | HC, IN | OR PLACE OF ORGANIZATION | 2021-02-16 | ↗ |
| 31 | Advisors LLC | 61.3K | 0.35% | — | 61.3K | — | — | IA | Delaware | 2020-02-14 | ↗ |
| 32 | Cubist Systematic Strategies, LLC | 4.5K | 4.00% | — | 4.5K | — | 4.5K | OO | Citizenship or place of organization Delaware | 2022-02-14 | ↗ |
| 33 | 52-0556948 | 912.00 | 0.00% | 912.00 | — | 912.00 | — | IA | Maryland | 2021-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
65
-278 vs prev Q
New positions
14
Closed positions
285
Increased
32
Reduced
18
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | FMR LLC | 4.35M +8.2K (+0.2%) | 1.07B +306.0M (+39.9%) | 15.02% +0.006 pp | 0.05% +0.015 pp | USD108.44 +127.4% | 34 qtrs — |
| 2 | BLACKROCK, INC. | 3.94M +103.7K (+2.7%) | 970.83M +294.0M (+43.4%) | 13.61% +0.343 pp | 0.02% +0.005 pp | USD183.48 +34.4% | 6 qtrs — |
| 3 | AVORO CAPITAL ADVISORS LLC | 2.89M +111.1K (+4.0%) | 712.23M +221.9M (+45.2%) | 9.98% +0.373 pp | 6.85% +0.509 pp | USD105.41 +133.9% | 17 qtrs — |
| 4 | VANGUARD GROUP INC | 2.78M -13.4K (-0.5%) | 685.10M +192.2M (+39.0%) | 9.60% -0.058 pp | 0.01% +0.003 pp | USD97.67 +152.4% | 33 qtrs — |
| 5 | STATE STREET CORP | 1.34M -53.7K (-3.8%) | 330.93M +84.5M (+34.3%) | 4.64% -0.191 pp | 0.01% +0.003 pp | USD115.26 +113.9% | 28 qtrs — |
| 6 | SOLEUS CAPITAL MANAGEMENT, L.P. | 941.1K -77.8K (-7.6%) | 232.01M +52.2M (+29.0%) | 3.25% -0.274 pp | 8.56% -0.496 pp | USD152.58 +61.6% | 21 qtrs — |
| 7 | CAPITAL WORLD INVESTORS | 809.5K +260.0 (+0.0%) | 199.57M +56.7M (+39.7%) | 2.80% -0.003 pp | 0.03% +0.008 pp | USD181.50 +35.8% | 8 qtrs — |
| 8 | REDMILE GROUP, LLC | 677.7K +16.3K (+2.5%) | 167.08M +50.3M (+43.1%) | 2.34% +0.053 pp | 12.30% +0.945 pp | USD70.67 +248.9% | 29 qtrs — |
| 9 | HOOD RIVER CAPITAL MANAGEMENT LLC | 613.3K +6.4K (+1.0%) | 151.20M +44.1M (+41.1%) | 2.12% +0.020 pp | 1.66% +0.393 pp | USD90.31 +173.0% | 23 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 611.9K +634.0 (+0.1%) | 150.88M +43.0M (+39.8%) | 2.11% 0.000 pp | 0.01% +0.002 pp | USD83.67 +194.7% | 31 qtrs — |
| 11 | PRICE T ROWE ASSOCIATES INC /MD/ | 530.0K +62.9K (+13.5%) | 130.66M +48.2M (+58.5%) | 1.83% +0.215 pp | 0.01% +0.005 pp | USD167.61 +47.1% | 29 qtrs — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 493.0K -41.0K (-7.7%) | 121.54M +27.3M (+28.9%) | 1.70% -0.144 pp | 0.03% +0.005 pp | USD90.62 +172.1% | 23 qtrs — |
| 13 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 488.5K -200.0K (-29.1%) | 120.42M -1.1M (-0.9%) | 1.69% -0.694 pp | 3.23% -0.407 pp | USD68.67 +259.0% | 16 qtrs — |
| 14 | BELLEVUE GROUP AG | 410.3K +409.0K (+31,174.6%) | 101.16M +100.9M (+43,577.9%) | 1.42% +1.413 pp | 1.92% +1.912 pp | USD246.04 +0.2% | 17 qtrs — |
| 15 | CITADEL ADVISORS LLC | 386.5K -250.5K (-39.3%) | 95.29M -17.2M (-15.3%) | 1.34% -0.868 pp | 0.01% -0.003 pp | USD174.41 +41.4% | 18 qtrs — |
| 16 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 376.3K +227.0K (+152.1%) | 92.78M +66.4M (+252.0%) | 1.30% +0.783 pp | 0.26% +0.191 pp | USD209.31 +17.8% | 3 qtrs — |
| 17 | GOLDMAN SACHS GROUP INC | 293.5K -54.7K (-15.7%) | 72.37M +10.9M (+17.7%) | 1.01% -0.191 pp | 0.01% +0.001 pp | USD132.59 +85.9% | 28 qtrs — |
| 18 | NORGES BANK | 284.6K +284.6K (+100.0%) | 70.16M +70.2M (+100.0%) | 0.98% +0.983 pp | 0.01% +0.008 pp | USD246.54 +0.0% | 1 qtrs NEW |
| 19 | NORTHERN TRUST CORP | 247.4K -722.0 (-0.3%) | 61.00M +17.2M (+39.3%) | 0.85% -0.004 pp | 0.01% +0.002 pp | USD73.16 +237.0% | 29 qtrs — |
| 20 | FIRST TRUST ADVISORS LP | 245.3K -3.1K (-1.3%) | 60.47M +16.6M (+37.9%) | 0.85% -0.012 pp | 0.04% +0.011 pp | USD147.43 +67.2% | 6 qtrs — |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 242.8K -89.0 (0.0%) | 59.85M +17.0M (+39.6%) | 0.84% -0.002 pp | 0.01% +0.003 pp | USD92.00 +168.0% | 27 qtrs — |
| 22 | MORGAN STANLEY | 221.5K -13.1K (-5.6%) | 54.60M +13.2M (+31.9%) | 0.77% -0.046 pp | 0.00% +0.001 pp | USD134.22 +83.7% | 31 qtrs — |
| 23 | JANUS HENDERSON GROUP PLC | 219.4K +209.4K (+2,078.9%) | 54.15M +52.4M (+2,944.8%) | 0.76% +0.723 pp | 0.02% +0.023 pp | USD239.37 +3.0% | 13 qtrs — |
| 24 | BRAIDWELL LP | 202.1K -318.3K (-61.2%) | 49.83M -42.0M (-45.8%) | 0.70% -1.102 pp | 1.59% -1.132 pp | USD149.27 +65.2% | 13 qtrs — |
| 25 | BANK OF AMERICA CORP /DE/ | 190.8K +52.8K (+38.3%) | 47.04M +22.7M (+93.1%) | 0.66% +0.182 pp | 0.00% +0.002 pp | USD168.37 +46.4% | 29 qtrs — |
| 26 | NUVEEN, LLC | 189.1K -8.3K (-4.2%) | 46.62M +11.8M (+33.8%) | 0.65% -0.029 pp | 0.01% +0.003 pp | USD180.12 +36.9% | 4 qtrs — |
| 27 | MARSHALL WACE, LLP | 183.8K +54.8K (+42.5%) | 45.30M +22.5M (+99.0%) | 0.63% +0.189 pp | 0.04% +0.018 pp | USD176.20 +39.9% | 5 qtrs — |
| 28 | PRINCIPAL FINANCIAL GROUP INC | 165.1K +22.2K (+15.6%) | 40.70M +15.5M (+61.4%) | 0.57% +0.076 pp | 0.02% +0.008 pp | USD182.40 +35.2% | 15 qtrs — |
| 29 | UBS GROUP AG | 159.6K +29.4K (+22.6%) | 39.35M +16.4M (+71.2%) | 0.55% +0.101 pp | 0.01% +0.003 pp | USD174.66 +41.2% | 29 qtrs — |
| 30 | PICTET ASSET MANAGEMENT HOLDING SA | 156.6K -40.3K (-20.5%) | 38.60M +3.8M (+11.0%) | 0.54% -0.140 pp | 0.04% +0.004 pp | USD143.52 +71.8% | 10 qtrs — |
| 31 | BANK OF NEW YORK MELLON CORP | 151.3K -4.2K (-2.7%) | 37.30M +9.8M (+35.9%) | 0.52% -0.015 pp | 0.01% +0.001 pp | USD125.37 +96.6% | 29 qtrs — |
| 32 | WOODLINE PARTNERS LP | 150.6K +— (+0.0%) | 37.13M +10.5M (+39.7%) | 0.52% -0.001 pp | 0.14% +0.019 pp | USD129.00 +91.1% | 11 qtrs — |
| 33 | JPMORGAN CHASE & CO | 134.6K -11.7K (-8.0%) | 33.19M +7.4M (+28.5%) | 0.47% -0.041 pp | 0.00% +0.001 pp | USD115.77 +113.0% | 31 qtrs — |
| 34 | FRANKLIN RESOURCES INC | 125.7K +105.8K (+533.1%) | 30.98M +27.5M (+784.2%) | 0.43% +0.365 pp | 0.01% +0.007 pp | USD234.74 +5.0% | 20 qtrs — |
| 35 | ORBIMED ADVISORS LLC | 119.8K +17.1K (+16.6%) | 29.54M +11.4M (+62.8%) | 0.41% +0.059 pp | 0.61% +0.178 pp | USD182.47 +35.1% | 9 qtrs — |
| 36 | HANDELSBANKEN FONDER AB | 105.8K +39.0K (+58.4%) | 26.08M +14.3M (+121.2%) | 0.37% +0.134 pp | 0.08% +0.041 pp | USD128.10 +92.5% | 23 qtrs — |
| 37 | CAPTION MANAGEMENT, LLC | 105.3K +5.3K (+5.3%) | 25.96M +8.3M (+47.1%) | 0.36% +0.018 pp | 0.18% +0.040 pp | USD176.91 +39.4% | 11 qtrs — |
| 38 | VOYA INVESTMENT MANAGEMENT LLC | 103.3K +9.4K (+10.0%) | 25.46M +8.9M (+53.6%) | 0.36% +0.032 pp | 0.03% +0.009 pp | USD152.57 +61.6% | 26 qtrs — |
| 39 | TIMESSQUARE CAPITAL MANAGEMENT, LLC | 97.4K -21.1K (-17.8%) | 24.01M +3.1M (+14.8%) | 0.34% -0.074 pp | 0.36% +0.063 pp | USD143.77 +71.5% | 10 qtrs — |
| 40 | S SQUARED TECHNOLOGY, LLC | 96.2K -13.0K (-11.9%) | 23.72M +4.4M (+23.0%) | 0.33% -0.046 pp | 9.19% +1.856 pp | USD72.36 +240.7% | 30 qtrs — |
| 41 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 89.4K -11.1K (-11.0%) | 22.03M +4.3M (+24.3%) | 0.31% -0.039 pp | 0.07% +0.009 pp | USD175.89 +40.2% | 7 qtrs — |
| 42 | C WORLDWIDE GROUP HOLDING A/S | 85.8K +— (+0.0%) | 21.16M +6.0M (+39.7%) | 0.30% 0.000 pp | 0.37% +0.136 pp | USD47.33 +420.9% | 24 qtrs — |
| 43 | SEGALL BRYANT & HAMILL, LLC | 83.2K -2.0K (-2.4%) | 20.52M +5.5M (+36.4%) | 0.29% -0.007 pp | 0.28% +0.077 pp | USD181.10 +36.1% | 7 qtrs — |
| 44 | RAYMOND JAMES FINANCIAL INC | 76.5K +12.2K (+18.9%) | 18.97M +7.6M (+66.9%) | 0.26% +0.042 pp | 0.01% +0.002 pp | USD170.31 +44.8% | 5 qtrs — |
| 45 | BIONDO INVESTMENT ADVISORS, LLC | 68.1K +16.2K (+31.3%) | 16.80M +7.6M (+83.4%) | 0.24% +0.056 pp | 2.03% +0.884 pp | USD181.04 +36.2% | 3 qtrs — |
| 46 | RHUMBLINE ADVISERS | 66.4K -4.1K (-5.8%) | 16.38M +3.9M (+31.5%) | 0.23% -0.015 pp | 0.01% +0.003 pp | USD128.16 +92.4% | 27 qtrs — |
| 47 | LEGAL & GENERAL GROUP PLC | 63.4K -2.5K (-3.7%) | 15.62M +4.0M (+34.5%) | 0.22% -0.009 pp | 0.00% +0.001 pp | USD155.21 +58.8% | 27 qtrs — |
| 48 | ACT CAPITAL MANAGEMENT, LLC | 60.5K +60.5K (+100.0%) | 14.92M +14.9M (+100.0%) | 0.21% +0.209 pp | 12.06% +12.061 pp | USD246.54 +0.0% | 1 qtrs NEW |
| 49 | BARCLAYS PLC | 60.1K +3.5K (+6.2%) | 14.81M +4.5M (+43.9%) | 0.21% +0.012 pp | 0.00% +0.001 pp | USD151.76 +62.5% | 29 qtrs — |
| 50 | INVESCO LTD. | 60.0K -6.9K (-10.3%) | 14.79M +3.0M (+25.3%) | 0.21% -0.024 pp | 0.00% +0.000 pp | USD168.06 +46.7% | 20 qtrs — |
| 51 | TD ASSET MANAGEMENT INC | 54.1K +9.1K (+20.1%) | 13.35M +5.4M (+67.7%) | 0.19% +0.031 pp | 0.01% +0.004 pp | USD176.97 +39.3% | 11 qtrs — |
| 52 | BNP PARIBAS ARBITRAGE, SNC | 53.9K +44.7K (+487.3%) | 13.29M +11.7M (+720.3%) | 0.19% +0.155 pp | 0.01% +0.005 pp | USD231.61 +6.4% | 27 qtrs — |
| 53 | AMERIPRISE FINANCIAL INC | 52.3K -3.4K (-6.2%) | 12.91M +3.1M (+31.0%) | 0.18% -0.012 pp | 0.00% +0.001 pp | USD166.53 +48.0% | 10 qtrs — |
| 54 | SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 46.7K -13.2K (-22.1%) | 11.52M +933.4K (+8.8%) | 0.16% -0.046 pp | 0.05% +0.004 pp | USD67.86 +263.3% | 20 qtrs — |
| 55 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 45.2K -68.6K (-60.3%) | 11.14M -8.9M (-44.5%) | 0.16% -0.238 pp | 0.00% -0.001 pp | USD140.76 +75.1% | 21 qtrs — |
| 56 | SWISS NATIONAL BANK | 42.9K +900.0 (+2.1%) | 10.58M +3.2M (+42.7%) | 0.15% +0.003 pp | 0.01% +0.002 pp | USD79.53 +210.0% | 27 qtrs — |
| 57 | PALISADES INVESTMENT PARTNERS, LLC | 42.8K +1.4K (+3.3%) | 10.54M +3.2M (+44.3%) | 0.15% +0.005 pp | 3.98% +1.114 pp | USD182.12 +35.4% | 7 qtrs — |
| 58 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 40.6K +6.2K (+17.9%) | 10.06M +4.0M (+65.3%) | 0.14% +0.021 pp | 0.01% +0.003 pp | USD156.92 +57.1% | 27 qtrs — |
| 59 | ABRDN PLC | 39.4K -20.0K (-33.7%) | 9.70M -777.1K (-7.4%) | 0.14% -0.069 pp | 0.02% -0.002 pp | USD149.26 +65.2% | 8 qtrs — |
| 60 | CI PRIVATE WEALTH, LLC | 38.3K -784.0 (-2.0%) | 9.50M +2.6M (+37.4%) | 0.13% -0.003 pp | 0.01% +0.002 pp | USD178.84 +37.9% | 8 qtrs — |
| 61 | MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 37.3K -665.0 (-1.8%) | 9.19M +2.5M (+37.2%) | 0.13% -0.003 pp | 0.10% +0.026 pp | USD87.80 +180.8% | 25 qtrs — |
| 62 | FEDERATED HERMES, INC. | 34.5K +10.6K (+44.0%) | 8.52M +4.3M (+101.2%) | 0.12% +0.036 pp | 0.01% +0.007 pp | USD179.97 +37.0% | 6 qtrs — |
| 63 | HEALTHINVEST PARTNERS AB | 33.9K -8.3K (-19.8%) | 8.35M +7.6M (+955.5%) | 0.12% -0.029 pp | 2.66% -0.269 pp | USD170.85 +44.3% | 9 qtrs — |
| 64 | UBS ASSET MANAGEMENT AMERICAS INC | 33.6K -169.0K (-83.4%) | 8.29M -27.5M (-76.8%) | 0.12% -0.585 pp | 0.00% -0.006 pp | USD178.01 +38.5% | 25 qtrs — |
| 65 | SEI INVESTMENTS CO | 32.3K +8.9K (+38.1%) | 7.97M +3.8M (+92.9%) | 0.11% +0.031 pp | 0.01% +0.003 pp | USD178.20 +38.4% | 27 qtrs — |
| 66 | WELLS FARGO & COMPANY/MN | 31.6K +11.9K (+60.6%) | 7.78M +4.3M (+124.4%) | 0.11% +0.041 pp | 0.00% +0.001 pp | USD181.18 +36.1% | 31 qtrs — |
| 67 | ALLIANCEBERNSTEIN L.P. | 31.5K +1.6K (+5.4%) | 7.77M +2.5M (+47.2%) | 0.11% +0.005 pp | 0.00% +0.001 pp | USD93.22 +164.5% | 27 qtrs — |
| 68 | NEW YORK STATE COMMON RETIREMENT FUND | 31.3K +4.3K (+16.1%) | 7.73M +3.0M (+62.2%) | 0.11% +0.015 pp | 0.01% +0.004 pp | USD136.81 +80.2% | 29 qtrs — |
| 69 | CITIGROUP INC | 29.9K +20.3K (+210.3%) | 7.38M +5.7M (+333.3%) | 0.10% +0.070 pp | 0.00% +0.003 pp | USD215.89 +14.2% | 29 qtrs — |
| 70 | CASTLEARK MANAGEMENT LLC | 29.3K +29.3K (+100.0%) | 7.21M +7.2M (+100.0%) | 0.10% +0.101 pp | 0.21% +0.212 pp | USD246.54 +0.0% | 1 qtrs NEW |
| 71 | RUSSELL INVESTMENTS GROUP, LTD. | 29.0K +2.4K (+9.1%) | 7.14M +2.5M (+52.3%) | 0.10% +0.008 pp | 0.01% +0.003 pp | USD183.50 +34.4% | 12 qtrs — |
| 72 | PRUDENTIAL FINANCIAL INC | 27.0K +1.5K (+6.0%) | 6.66M +2.2M (+48.0%) | 0.09% +0.005 pp | 0.01% +0.003 pp | USD137.37 +79.5% | 16 qtrs — |
| 73 | VICTORY CAPITAL MANAGEMENT INC | 26.5K -28.4K (-51.7%) | 6.52M -3.2M (-32.6%) | 0.09% -0.098 pp | 0.00% -0.002 pp | USD85.20 +189.4% | 17 qtrs — |
| 74 | GRANITE INVESTMENT PARTNERS, LLC | 25.8K +25.8K (+100.0%) | 6.35M +6.4M (+100.0%) | 0.09% +0.089 pp | 0.38% +0.376 pp | USD246.54 +0.0% | 1 qtrs NEW |
| 75 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 25.0K +13.3K (+112.8%) | 6.16M +4.1M (+197.1%) | 0.09% +0.046 pp | 0.58% +0.347 pp | USD210.83 +16.9% | 8 qtrs — |
| 76 | EAM INVESTORS, LLC | 24.7K +24.7K (+100.0%) | 6.08M +6.1M (+100.0%) | 0.09% +0.085 pp | 0.68% +0.677 pp | USD246.54 +0.0% | 1 qtrs NEW |
| 77 | RAFFERTY ASSET MANAGEMENT, LLC | 24.3K -10.4K (-29.9%) | 5.98M -132.0K (-2.2%) | 0.08% -0.036 pp | 0.02% +0.001 pp | USD109.02 +126.1% | 26 qtrs — |
| 78 | JANE STREET GROUP, LLC | 23.8K -32.0K (-57.3%) | 5.87M -4.0M (-40.4%) | 0.08% -0.111 pp | 0.00% -0.001 pp | USD142.80 +72.6% | 6 qtrs — |
| 79 | — | 23.6K +23.6K (+100.0%) | 5.82M +5.8M (+100.0%) | 0.08% +0.081 pp | 0.11% +0.113 pp | USD246.54 +0.0% | 1 qtrs NEW |
| 80 | DEUTSCHE BANK AG\ | 22.5K +1.1K (+5.0%) | 5.53M +1.8M (+46.7%) | 0.08% +0.004 pp | 0.00% +0.001 pp | USD132.64 +85.9% | 30 qtrs — |
| 81 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 22.1K +689.0 (+3.2%) | 5.45M +1.7M (+44.0%) | 0.08% +0.002 pp | 0.01% +0.004 pp | USD178.55 +38.1% | 27 qtrs — |
| 82 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 20.6K -299.0 (-1.4%) | 5.07M +1.4M (+37.7%) | 0.07% -0.001 pp | 0.01% +0.001 pp | USD67.48 +265.4% | 27 qtrs — |
| 83 | BESSEMER GROUP INC | 20.3K +20.1K (+13,497.3%) | 5.00M +5.0M (+19,111.5%) | 0.07% +0.070 pp | 0.01% +0.008 pp | USD246.04 +0.2% | 7 qtrs — |
| 84 | ADAR1 CAPITAL MANAGEMENT, LLC | 20.0K +1.5K (+8.0%) | 4.93M +1.7M (+50.9%) | 0.07% +0.005 pp | 0.36% +0.055 pp | USD181.75 +35.6% | 2 qtrs — |
| 85 | GW&K INVESTMENT MANAGEMENT, LLC | 19.6K +9.1K (+86.6%) | 4.83M +3.0M (+160.6%) | 0.07% +0.031 pp | 0.04% +0.025 pp | USD208.78 +18.1% | 8 qtrs — |
| 86 | SG AMERICAS SECURITIES, LLC | 18.9K +15.6K (+469.9%) | 4.66M +4.1M (+695.6%) | 0.07% +0.054 pp | 0.01% +0.004 pp | USD228.18 +8.0% | 23 qtrs — |
| 87 | FIERA CAPITAL CORP | 18.9K +3.8K (+25.2%) | 4.65M +2.0M (+74.8%) | 0.07% +0.013 pp | 0.01% +0.006 pp | USD149.53 +64.9% | 9 qtrs — |
| 88 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 17.9K +3.6K (+25.4%) | 4.41M +1.9M (+75.1%) | 0.06% +0.013 pp | 0.05% +0.021 pp | USD192.68 +28.0% | 7 qtrs — |
| 89 | THRIVENT FINANCIAL FOR LUTHERANS | 17.7K -850.0 (-4.6%) | 4.37M +1.1M (+33.3%) | 0.06% -0.003 pp | 0.01% +0.001 pp | USD182.01 +35.5% | 7 qtrs — |
| 90 | 1832 ASSET MANAGEMENT L.P. | 17.6K +17.6K (+100.0%) | 4.34M +4.3M (+100.0%) | 0.06% +0.061 pp | 0.00% +0.003 pp | USD246.54 +0.0% | 1 qtrs NEW |
| 91 | PERCEPTIVE ADVISORS LLC | 17.5K -17.5K (-50.0%) | 4.31M -1.9M (-30.2%) | 0.06% -0.061 pp | 0.08% -0.102 pp | USD176.53 +39.7% | 2 qtrs — |
| 92 | DECHENG CAPITAL LLC | 17.3K -15.0K (-46.4%) | 4.27M -1.4M (-25.2%) | 0.06% -0.052 pp | 0.57% -0.421 pp | USD130.82 +88.5% | 9 qtrs — |
| 93 | VERITION FUND MANAGEMENT LLC | 17.0K -14.4K (-45.8%) | 4.18M -1.3M (-24.4%) | 0.06% -0.050 pp | 0.02% -0.006 pp | USD125.58 +96.3% | 27 qtrs — |
| 94 | EVOLUTIONARY TREE CAPITAL MANAGEMENT, LLC | 16.8K +4.4K (+34.9%) | 4.14M +1.9M (+88.4%) | 0.06% +0.015 pp | 4.81% +2.415 pp | USD167.82 +46.9% | 9 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.29
Bearish
Ratio by volume
1.00
Neutral
Buys
22
Sells
75
Shares acquired
363.1K
Shares disposed
364.2K
Cash buys
—
Cash sales
52.00
Net activity
-1,061
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 668 | 259.61 | 173.4K | 1,426,491 | D | ↗ |
| 2026-03-04 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 470 | 258.38 | 121.4K | 1,499,300 | D | ↗ |
| 2026-03-02 | ROMANO KATHRYN | Officer | S-Sale | D | Common Stock | 750 | 267.60 | 200.7K | 22,366 | D | ↗ |
| 2026-03-01 | Thomas John Charles | Officer | — | — | Stock Option (Right to Buy) | 32,400 | 52.21 | 1.69M | 0 | D | ↗ |
| 2026-03-01 | Goux Laurent Louis Jean | Officer | — | — | Common Stock | 0 | 0.00 | — | 919 | D | ↗ |
| 2026-02-27 | ROMANO KATHRYN | Officer | M-Exempt | D | Restricted Stock Units | 550 | 0.00 | — | 1,650 | D | ↗ |
| 2026-02-27 | Krishnan Suma | Director / Officer / 10% Owner | M-Exempt | D | Performance Stock Units | 22,500 | 0.00 | — | 0 | D | ↗ |
| 2026-02-27 | Krishnan Krish S | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 4,000 | 0.00 | — | 1,429,975 | I | ↗ |
| 2026-02-27 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 9,430 | 275.45 | 2.60M | 75,666 | I | ↗ |
| 2026-02-26 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 5,103 | 275.28 | 1.40M | 87,734 | I | ↗ |
| 2026-02-25 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 700 | 275.00 | 192.5K | 92,837 | I | ↗ |
| 2026-02-24 | JANNEY DANIEL | Director | M-Exempt | D | Stock Option (Right to Buy) | 37,895 | 2.46 | 93.2K | 0 | D | ↗ |
| 2026-02-19 | ROSSI DINO A | Director | M-Exempt | A | Common Stock | 18,950 | 8.79 | 166.6K | 97,641 | D | ↗ |
| 2026-02-09 | ROMANO KATHRYN | Officer | S-Sale | D | Common Stock | 928 | 273.71 | 254.0K | 20,366 | D | ↗ |
| 2025-12-05 | Krishnan Suma | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 5,000 | 0.00 | — | 1,478,056 | I | ↗ |
| 2025-12-05 | Krishnan Krish S | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 5,000 | 0.00 | — | 1,478,056 | D | ↗ |
| 2025-12-04 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200 | 222.38 | 44.5K | 1,413,711 | D | ↗ |
| 2025-12-04 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,600 | 217.04 | 347.3K | 1,505,156 | D | ↗ |
| 2025-07-16 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,529 | 150.00 | 229.4K | 1,438,711 | D | ↗ |
| 2025-07-16 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,389 | 150.00 | 208.4K | 1,508,056 | D | ↗ |
| 2025-07-15 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,236 | 150.68 | 336.9K | 1,441,040 | D | ↗ |
| 2025-07-15 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,184 | 150.68 | 329.1K | 1,510,345 | D | ↗ |
| 2025-07-14 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 13,335 | 150.29 | 2.00M | 1,443,376 | D | ↗ |
| 2025-07-14 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 13,335 | 150.29 | 2.00M | 1,443,376 | I | ↗ |
| 2025-07-10 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,500 | 150.23 | 976.5K | 1,457,011 | D | ↗ |
| 2025-07-10 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,500 | 150.23 | 976.5K | 1,457,011 | I | ↗ |
| 2025-07-09 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200 | 150.14 | 30.0K | 1,463,511 | D | ↗ |
| 2025-07-09 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200 | 150.14 | 30.0K | 1,463,511 | I | ↗ |
| 2025-06-30 | Sutherland Everett Rand | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 137.46 | 687.3K | 5,000 | D | ↗ |
| 2025-06-30 | ROSSI DINO A | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 137.46 | 687.3K | 5,000 | D | ↗ |
| 2025-06-30 | Mazzacco Catherine | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 137.46 | 687.3K | 5,000 | D | ↗ |
| 2025-06-30 | Mason Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 137.46 | 687.3K | 5,000 | D | ↗ |
| 2025-06-30 | JANNEY DANIEL | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 137.46 | 687.3K | 5,000 | D | ↗ |
| 2025-06-30 | Gangolli Julian S | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 137.46 | 687.3K | 5,000 | D | ↗ |
| 2025-03-13 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,331 | 179.55 | 239.0K | 1,463,711 | D | ↗ |
| 2025-03-13 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,331 | 179.55 | 239.0K | 1,463,711 | I | ↗ |
| 2025-02-28 | ROMANO KATHRYN | Officer | M-Exempt | A | Common Stock | 7,500 | 0.00 | — | 22,789 | D | ↗ |
| 2025-02-28 | Krishnan Suma | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 25,000 | 179.25 | 4.48M | 25,000 | D | ↗ |
| 2025-02-28 | Krishnan Krish S | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,050 | 179.25 | 726.0K | 1,543,955 | D | ↗ |
| 2025-02-27 | ROMANO KATHRYN | Officer | S-Sale | D | Common Stock | 750 | 175.22 | 131.4K | 12,604 | D | ↗ |
| 2025-02-26 | ROMANO KATHRYN | Officer | F-InKind | D | Common Stock | 2,268 | 176.39 | 400.1K | 13,354 | D | ↗ |
| 2025-02-26 | Krishnan Suma | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,286 | 176.39 | 579.6K | 1,472,596 | D | ↗ |
| 2025-02-26 | Krishnan Krish S | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,721 | 176.39 | 832.7K | 1,532,541 | D | ↗ |
| 2024-12-13 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 200 | 168.31 | 33.7K | 1,478,182 | D | ↗ |
| 2024-12-13 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 923 | 166.93 | 154.1K | 1,539,770 | D | ↗ |
| 2024-09-13 | ROSSI DINO A | Director | G-Gift | D | Common Stock | 5,000 | 0.00 | — | 78,691 | — | ↗ |
| 2024-09-12 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,895 | 201.52 | 381.9K | 1,500,882 | — | ↗ |
| 2024-09-12 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 800 | 201.81 | 161.4K | 1,562,262 | — | ↗ |
| 2024-06-30 | Sutherland Everett Rand | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 183.64 | 918.2K | 5,000 | — | ↗ |
| 2024-06-30 | ROSSI DINO A | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 183.64 | 918.2K | 5,000 | — | ↗ |
| 2024-06-30 | Mazzacco Catherine | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 183.64 | 918.2K | 5,000 | — | ↗ |
| 2024-06-30 | Mason Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 183.64 | 918.2K | 5,000 | — | ↗ |
| 2024-06-30 | JANNEY DANIEL | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 183.64 | 918.2K | 5,000 | — | ↗ |
| 2024-06-30 | Gangolli Julian S | Director | A-Award | A | Stock Option (Right to Buy) | 5,000 | 183.64 | 918.2K | 5,000 | — | ↗ |
| 2024-06-11 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,871 | 178.14 | 333.3K | 1,525,882 | — | ↗ |
| 2024-06-11 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 998 | 178.36 | 178.0K | 1,587,262 | — | ↗ |
| 2024-05-20 | Gangolli Julian S | Director | S-Sale | D | Common Stock | 10,930 | 163.71 | 1.79M | 9,070 | — | ↗ |
| 2024-03-11 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,587 | 173.30 | 621.6K | 1,551,682 | — | ↗ |
| 2024-03-11 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,469 | 171.09 | 935.7K | 1,558,069 | — | ↗ |
| 2024-02-29 | ROMANO KATHRYN | Officer | A-Award | A | Performance Stock Units | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2024-02-29 | Krishnan Suma | Director / Officer / 10% Owner | A-Award | A | Performance Stock Units | 45,000 | 0.00 | — | 45,000 | — | ↗ |
| 2024-02-29 | Krishnan Krish S | Director / Officer / 10% Owner | A-Award | A | Performance Stock Units | 52,500 | 0.00 | — | 52,500 | — | ↗ |
| 2024-02-28 | ROMANO KATHRYN | Officer | M-Exempt | A | Common Stock | 1,216 | 63.55 | 77.3K | 14,152 | — | ↗ |
| 2024-02-28 | Krishnan Suma | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 1,643,047 | — | ↗ |
| 2024-02-28 | Krishnan Krish S | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 5,785 | 163.08 | 943.4K | 1,637,262 | — | ↗ |
| 2024-02-27 | ROMANO KATHRYN | Officer | M-Exempt | D | Stock Option (Right to Buy) | 1,913 | 52.26 | 100.0K | 0 | — | ↗ |
| 2024-02-26 | ROMANO KATHRYN | Officer | S-Sale | D | Common Stock | 3,087 | 140.00 | 432.2K | 12,556 | — | ↗ |
| 2024-02-26 | Krishnan Suma | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,353 | 157.00 | 369.4K | 1,571,853 | — | ↗ |
| 2024-02-26 | Krishnan Krish S | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,791 | 157.00 | 595.2K | 1,630,547 | — | ↗ |
| 2024-01-22 | Romano Kathryn | Officer | M-Exempt | A | Common Stock | 2,500 | 52.26 | 130.7K | 15,056 | — | ↗ |
| 2023-12-11 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100 | 107.66 | 10.8K | 1,574,206 | — | ↗ |
| 2023-12-11 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100 | 107.66 | 10.8K | 1,574,206 | — | ↗ |
| 2023-09-11 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,110 | 129.10 | 272.4K | 1,599,206 | — | ↗ |
| 2023-09-11 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,110 | 129.10 | 272.4K | 1,659,338 | — | ↗ |
| 2023-06-30 | Sutherland Everett Rand | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 117.40 | 798.3K | 6,800 | — | ↗ |
| 2023-06-30 | ROSSI DINO A | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 117.40 | 798.3K | 6,800 | — | ↗ |
| 2023-06-30 | Mazzacco Catherine | Director | A-Award | A | Stock Option (Right to Buy) | 2,180 | 117.40 | 255.9K | 2,180 | — | ↗ |
| 2023-06-30 | Mason Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 117.40 | 798.3K | 6,800 | — | ↗ |
| 2023-06-30 | JANNEY DANIEL | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 117.40 | 798.3K | 6,800 | — | ↗ |
| 2023-06-30 | Gangolli Julian S | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 117.40 | 798.3K | 6,800 | — | ↗ |
| 2023-06-09 | ORTH ANDREW C. | Officer | S-Sale | D | Common Stock | 6,906 | 128.94 | 890.5K | 433 | — | ↗ |
| 2023-06-09 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 3,935 | 129.29 | 508.8K | 122,362 | — | ↗ |
| 2023-06-08 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 5,000 | 127.86 | 639.3K | 126,297 | — | ↗ |
| 2023-05-31 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 300 | 117.57 | 35.3K | 1,624,206 | — | ↗ |
| 2023-05-31 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 300 | 117.57 | 35.3K | 1,624,206 | — | ↗ |
| 2023-05-22 | Romano Kathryn | Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,500 | 52.26 | 653.3K | 12,500 | — | ↗ |
| 2023-05-19 | Romano Kathryn | Officer | S-Sale | D | Common Stock | 3,428 | 95.08 | 325.9K | 12,556 | — | ↗ |
| 2023-05-19 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 50,000 | 95.02 | 4.75M | 157,362 | — | ↗ |
| 2023-05-09 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 17,100 | 90.74 | 1.55M | 207,362 | — | ↗ |
| 2023-04-19 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 7,900 | 90.32 | 713.5K | 224,462 | — | ↗ |
| 2023-04-17 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 500 | 89.12 | 44.6K | 1,649,206 | — | ↗ |
| 2023-04-17 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 500 | 89.12 | 44.6K | 1,652,263 | — | ↗ |
| 2023-03-31 | Mazzacco Catherine | Director | A-Award | A | Stock Option (Right to Buy) | 13,600 | 80.06 | 1.09M | 13,600 | — | ↗ |
| 2023-03-06 | Mazzacco Catherine | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-03-01 | ROSSI DINO A | Director | S-Sale | D | Common Stock | 40,000 | 83.25 | 3.33M | 83,691 | — | ↗ |
| 2023-02-28 | Romano Kathryn | Officer | A-Award | A | Performance Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2023-02-28 | ORTH ANDREW C. | Officer | A-Award | A | Performance Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2023-02-28 | Krishnan Suma | Director / Officer / 10% Owner | A-Award | A | Performance Stock Units | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2023-02-28 | Krishnan Krish S | Director / Officer / 10% Owner | A-Award | A | Performance Stock Units | 25,000 | 0.00 | — | 25,000 | — | ↗ |
| 2023-02-26 | Romano Kathryn | Officer | F-InKind | D | Common Stock | 2,144 | 78.46 | 168.2K | 15,984 | — | ↗ |
| 2023-02-26 | Krishnan Suma | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,057 | 78.46 | 239.9K | 1,674,206 | — | ↗ |
| 2023-02-26 | Krishnan Krish S | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,350 | 78.46 | 341.3K | 1,734,338 | — | ↗ |
| 2023-01-18 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 2,048 | 80.75 | 165.4K | 1,678,067 | — | ↗ |
| 2023-01-18 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 804 | 81.56 | 65.6K | 1,677,263 | — | ↗ |
| 2023-01-17 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 20,617 | 80.70 | 1.66M | 1,681,646 | — | ↗ |
| 2023-01-17 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 345 | 82.72 | 28.5K | 1,680,115 | — | ↗ |
| 2023-01-04 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 3,748 | 80.08 | 300.1K | 1,763,688 | — | ↗ |
| 2023-01-04 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 3,748 | 80.08 | 300.1K | 1,763,688 | — | ↗ |
| 2023-01-03 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 1,700 | 80.33 | 136.6K | 1,767,436 | — | ↗ |
| 2023-01-03 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 1,700 | 80.33 | 136.6K | 1,706,201 | — | ↗ |
| 2022-12-29 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 7,484 | 80.30 | 601.0K | 1,708,429 | — | ↗ |
| 2022-12-29 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 7,447 | 80.28 | 597.8K | 1,769,699 | — | ↗ |
| 2022-12-16 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 10,572 | 80.10 | 846.8K | 1,777,146 | — | ↗ |
| 2022-12-16 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 10,572 | 80.10 | 846.8K | 1,777,146 | — | ↗ |
| 2022-11-23 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 4 | 80.01 | 320.04 | 1,787,718 | — | ↗ |
| 2022-11-23 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 4 | 80.01 | 320.04 | 1,787,718 | — | ↗ |
| 2022-11-08 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 823 | 80.04 | 65.9K | 1,726,440 | — | ↗ |
| 2022-11-08 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 823 | 80.04 | 65.9K | 1,726,440 | — | ↗ |
| 2022-08-05 | Krishnan Suma | Officer | S-Sale | D | Common Stock | 9,088 | 80.24 | 729.2K | 1,804,600 | — | ↗ |
| 2022-08-05 | Krishnan Krish S | Officer | S-Sale | D | Common Stock | 8,992 | 80.22 | 721.3K | 1,743,271 | — | ↗ |
| 2022-06-30 | Sutherland Everett Rand | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 0.00 | — | 6,800 | — | ↗ |
| 2022-06-30 | ROSSI DINO A | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 65.66 | 446.5K | 6,800 | — | ↗ |
| 2022-06-30 | Mason Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 0.00 | — | 6,800 | — | ↗ |
| 2022-06-30 | JANNEY DANIEL | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 0.00 | — | 6,800 | — | ↗ |
| 2022-06-30 | Gangolli Julian S | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 0.00 | — | 6,800 | — | ↗ |
| 2022-02-28 | Romano Kathryn | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 63.55 | 3.18M | 50,000 | — | ↗ |
| 2022-02-28 | ORTH ANDREW C. | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 63.55 | 3.18M | 50,000 | — | ↗ |
| 2022-02-28 | Krishnan Suma | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 50,000 | 63.55 | 3.18M | 50,000 | — | ↗ |
| 2022-02-28 | Krishnan Krish S | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 50,000 | 63.55 | 3.18M | 50,000 | — | ↗ |
| 2022-02-26 | Romano Kathryn | Officer | F-InKind | D | Common Stock | 1,472 | 62.50 | 92.0K | 18,128 | — | ↗ |
| 2022-02-26 | Krishnan Suma | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,282 | 62.50 | 205.1K | 1,752,263 | — | ↗ |
| 2022-02-26 | Krishnan Krish S | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 4,655 | 62.50 | 290.9K | 1,813,688 | — | ↗ |
| 2022-01-31 | Sutherland Everett Rand | Director | A-Award | A | Stock Option (Right to Buy) | 13,600 | 59.00 | 802.4K | 13,600 | — | ↗ |
| 2022-01-31 | Marantz Jing L. | Officer | A-Award | A | Stock Option (Right to Buy) | 205,000 | 59.00 | 12.10M | 205,000 | — | ↗ |
| 2022-01-18 | Sutherland Everett Rand | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-30 | JANNEY DANIEL | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-10 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 70.50 | 7.05M | 50,000 | — | ↗ |
| 2021-12-10 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 70.50 | 7.05M | 50,000 | — | ↗ |
| 2021-12-10 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 100,000 | 70.50 | 7.05M | 266,362 | — | ↗ |
| 2021-06-30 | ROSSI DINO A | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 68.00 | 462.4K | 6,800 | — | ↗ |
| 2021-06-30 | Mason Christopher | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 68.00 | 462.4K | 6,800 | — | ↗ |
| 2021-06-30 | Marantz Jing L. | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 68.00 | 462.4K | 6,800 | — | ↗ |
| 2021-06-30 | JANNEY DANIEL | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 68.00 | 462.4K | 6,800 | — | ↗ |
| 2021-06-30 | Gangolli Julian S | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 68.00 | 462.4K | 6,800 | — | ↗ |
| 2021-06-01 | ROSSI DINO A | Director | — | D | Stock Option (Right to Buy) | 18,949 | 39.57 | 749.8K | 0 | — | ↗ |
| 2021-05-31 | ORTH ANDREW C. | Officer | A-Award | A | Stock Option (Right to Buy) | 205,000 | 65.24 | 13.37M | 205,000 | — | ↗ |
| 2021-05-01 | ORTH ANDREW C. | Officer | — | D | Common Stock | 0 | 0.00 | — | 100 | — | ↗ |
| 2021-02-26 | Romano Kathryn | Officer | A-Award | A | Stock Option (Right to Buy) | 29,400 | 78.89 | 2.32M | 29,400 | — | ↗ |
| 2021-02-26 | Krishnan Suma | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 42,600 | 78.89 | 3.36M | 42,600 | — | ↗ |
| 2021-02-26 | Krishnan Krish S | Director / Officer / 10% Owner | A-Award | A | Common Stock | 40,800 | 0.00 | — | 1,927,262 | — | ↗ |
| 2021-01-04 | Mason Christopher | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-04 | Marantz Jing L. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-11-30 | NORBY R DOUGLAS | Director | — | D | Stock Option (Right to Buy) | 18,949 | 2.46 | 46.6K | 0 | — | ↗ |
| 2020-11-10 | JANNEY DANIEL | Director | — | D | Stock Option (Right to Buy) | 37,894 | 11.07 | 419.5K | 0 | — | ↗ |
| 2020-09-17 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,126 | 47.29 | 53.2K | 1,836,064 | — | ↗ |
| 2020-09-16 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,142 | 46.85 | 240.9K | 1,855,221 | — | ↗ |
| 2020-09-15 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 14,435 | 46.21 | 667.0K | 1,871,629 | — | ↗ |
| 2020-06-30 | ROSSI DINO A | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 41.42 | 281.7K | 6,800 | — | ↗ |
| 2020-06-30 | JANNEY DANIEL | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 41.42 | 281.7K | 6,800 | — | ↗ |
| 2020-06-30 | Gangolli Julian S | Director | A-Award | A | Stock Option (Right to Buy) | 6,800 | 41.42 | 281.7K | 6,800 | — | ↗ |
| 2020-06-15 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 8,652 | 42.24 | 365.4K | 1,919,834 | — | ↗ |
| 2020-05-18 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,301 | 59.73 | 376.3K | 1,886,462 | — | ↗ |
| 2020-05-15 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,842 | 57.43 | 220.6K | 1,932,620 | — | ↗ |
| 2020-03-18 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 659 | 40.20 | 26.5K | 1,936,064 | — | ↗ |
| 2020-03-17 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,396 | 41.27 | 57.6K | 1,936,727 | — | ↗ |
| 2020-03-16 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,559 | 40.14 | 102.7K | 1,948,903 | — | ↗ |
| 2020-02-20 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,022 | 60.71 | 608.4K | 1,942,929 | — | ↗ |
| 2020-02-19 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,617 | 63.15 | 165.3K | 1,955,143 | — | ↗ |
| 2020-02-18 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 600 | 63.95 | 38.4K | 1,973,793 | — | ↗ |
| 2020-01-31 | Romano Kathryn | Officer | A-Award | A | Stock Option (Right to Buy) | 50,000 | 52.26 | 2.61M | 50,000 | — | ↗ |
| 2020-01-31 | Chien Jennifer | Officer | A-Award | A | Stock Option (Right to Buy) | 125,000 | 52.26 | 6.53M | 125,000 | — | ↗ |
| 2020-01-20 | Romano Kathryn | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-20 | Chien Jennifer | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-12-18 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 239 | 63.31 | 15.1K | 1,951,462 | — | ↗ |
| 2019-12-17 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 279 | 63.35 | 17.7K | 1,960,574 | — | ↗ |
| 2019-12-16 | Krishnan Suma | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,373 | 62.84 | 463.4K | 1,994,089 | — | ↗ |
| 2019-11-19 | Riley Antony A | Officer | M-Exempt | D | Stock Option (Right to Buy) | 6,250 | 9.85 | 61.6K | 18,750 | — | ↗ |
| 2019-11-18 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 400 | 54.38 | 21.8K | 1,986,462 | — | ↗ |
| 2019-11-15 | Krishnan Krish S | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,598 | 51.47 | 236.7K | 2,008,583 | — | ↗ |
| 2019-08-30 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 32,190 | 46.18 | 1.49M | 366,362 | — | ↗ |
| 2019-08-29 | JANNEY DANIEL | Director | S-Sale | D | Common Stock | 700 | 47.50 | 33.3K | 398,552 | — | ↗ |
| 2019-06-01 | Riley Antony A | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 31.42 | 785.5K | 25,000 | — | ↗ |
| 2019-03-22 | Riley Antony A | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 25.02 | 625.5K | 25,000 | — | ↗ |
| 2019-03-01 | Gangolli Julian S | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-10-18 | Krishnan Suma | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 25,000 | 20.00 | 500.0K | 2,001,462 | — | ↗ |
| 2018-10-18 | Krishnan Krish S | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 25,000 | 20.00 | 500.0K | 2,036,462 | — | ↗ |
| 2018-06-06 | Krishnan Suma | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 1,018 | 12.45 | 12.7K | 1,976,462 | — | ↗ |
| 2018-06-05 | Krishnan Suma | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 10,866 | 10.75 | 116.8K | 1,962,328 | — | ↗ |
| 2018-06-01 | Krishnan Suma | Director / Officer / 10% Owner | J-Other | A | Common Stock | 16,213 | 0.00 | — | 1,951,462 | — | ↗ |
| 2018-06-01 | Krishnan Krish S | Director / Officer / 10% Owner | J-Other | A | Common Stock | 26,213 | 0.00 | — | 2,011,462 | — | ↗ |
| 2018-05-31 | ROSSI DINO A | Director | A-Award | A | Stock Option (Right to Buy) | 7,500 | 10.29 | 77.2K | 7,500 | — | ↗ |
| 2018-05-31 | NORBY R DOUGLAS | Director | A-Award | A | Stock Option (Right to Buy) | 7,500 | 10.29 | 77.2K | 7,500 | — | ↗ |
| 2018-05-31 | JANNEY DANIEL | Director | A-Award | A | Stock Option (Right to Buy) | 7,500 | 10.29 | 77.2K | 7,500 | — | ↗ |
| 2018-05-22 | Riley Antony A | Officer | P-Purchase | A | Common Stock | 2,800 | 10.75 | 30.1K | 2,800 | — | ↗ |
| 2018-05-09 | NORBY R DOUGLAS | Director | P-Purchase | A | Common Stock | 9,000 | 10.42 | 93.8K | 9,000 | — | ↗ |
| 2018-03-19 | Krishnan Krish S | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 11.00 | 550.0K | 1,985,249 | — | ↗ |
| 2018-03-08 | Riley Antony A | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 9.85 | 246.3K | 25,000 | — | ↗ |
| 2017-09-22 | ROSSI DINO A | Director | C-Conversion | D | Series A Convertible Preferred Stock | 123,691 | 0.00 | — | 0 | — | ↗ |
| 2017-09-22 | Krishnan Suma | Director / Officer / 10% Owner | C-Conversion | D | Series A Convertible Preferred Stock | 112,162 | 0.00 | — | 0 | — | ↗ |
| 2017-09-22 | Krishnan Krish S | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 100,000 | 10.00 | 1.00M | 1,935,249 | — | ↗ |
Executive team
Top executives
EBIT / Employee
586.5K
Shares Outstanding
29.44M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Krish S. Krishnan Chair and Chief Executive Officer | 846.2K | 682.4K | 4.10M | 4.68M | — | 134.0K | 10.44M | 84.08% | ↗ |
| 2 | 2025 | Suma M. Krishnan President, R&D | 677.5K | 414.9K | 2.87M | 2.97M | — | 14.0K | 6.95M | 84.08% | ↗ |
| 3 | 2025 | Kathryn A. Romano Chief Accounting Officer | 437.5K | 223.3K | 394.4K | 1.19M | — | 14.0K | 2.26M | 70.13% | ↗ |
| 4 | 2024 | Krish S. Krishnan Chair and Chief Executive Officer | 801.7K | 714.6K | 13.95M | — | — | 133.8K | 15.60M | 89.43% | ↗ |
| 5 | 2024 | Suma M. Krishnan President, R&D | 639.2K | 414.7K | 7.18M | — | — | 13.8K | 8.24M | 87.05% | ↗ |
| 6 | 2024 | Kathryn A. Romano Chief Accounting Officer | 416.7K | 231.0K | 2.39M | — | — | 13.8K | 3.05M | 78.34% | ↗ |
| 7 | 2023 | Krish S. Krishnan Chair and Chief Executive Officer | 733.3K | 487.5K | 2.05M | 2.85M | — | 102.8K | 6.22M | 78.73% | ↗ |
| 8 | 2023 | Suma M. Krishnan President, R&D | 575.0K | 307.1K | 1.23M | 1.71M | — | 13.2K | 3.84M | 76.66% | ↗ |
| 9 | 2023 | Kathryn A. Romano Chief Accounting Officer | 391.7K | 210.0K | 819.1K | 1.14M | — | 13.2K | 2.57M | 76.12% | ↗ |
| 10 | 2023 | Andrew C. Orth Chief Commercial Officer | 276.5K | — | 819.1K | 1.14M | — | 27.7K | 2.26M | 86.56% | ↗ |
| 11 | 2022 | Krish S. Krishnan Chair and Chief Executive Officer | 644.8K | 325.0K | — | 2.19M | — | 97.0K | 3.26M | 67.24% | ↗ |
| 12 | 2022 | Suma M. Krishnan President, R&D | 514.8K | 262.5K | — | 2.19M | — | 12.6K | 2.98M | 73.49% | ↗ |
| 13 | 2022 | Andrew C. Orth Chief Commercial Officer | 445.8K | 202.5K | — | 2.19M | — | 12.2K | 2.85M | 76.82% | ↗ |
| 14 | 2022 | Kathryn A. Romano Chief Accounting Officer | 341.7K | 175.0K | — | 2.19M | — | 12.2K | 2.72M | 80.55% | ↗ |
| 15 | 2021 | Andrew C. Orth Chief Commercial Officer | 283.3K | 130.5K | — | 8.58M | — | 9.9K | 9.00M | 95.29% | ↗ |
| 16 | 2021 | Krish S. Krishnan Chair and Chief Executive Officer | 581.0K | 309.5K | 3.22M | 3.12M | — | 118.4K | 7.35M | 86.27% | ↗ |
| 17 | 2021 | Suma M. Krishnan President, R&D | 453.4K | 243.6K | 2.24M | 2.17M | — | 11.6K | 5.12M | 86.17% | ↗ |
| 18 | 2021 | Kathryn A. Romano Chief Accounting Officer | 283.3K | 157.5K | 1.55M | 1.50M | — | 11.6K | 3.50M | 87.07% | ↗ |
| 19 | 2020 | Kathryn A. Romano Chief Accounting Officer | 190.6K | 75.6K | — | 1.72M | — | 6.7K | 1.99M | 86.31% | ↗ |
| 20 | 2020 | Krish S. Krishnan Chair and Chief Executive Officer | 498.2K | 254.2K | — | — | — | 11.4K | 763.8K | 0.00% | ↗ |
| 21 | 2020 | Krish S. Krishnan Chairman and Chief Executive Officer | 498.2K | 254.2K | — | — | — | — | 752.4K | 0.00% | ↗ |
| 22 | 2020 | Suma M. Krishnan President, R&D | 392.2K | 200.1K | — | — | — | 10.7K | 603.0K | 0.00% | ↗ |
| 23 | 2020 | Suma M. Krishnan Chief Operating Officer | 392.2K | 140.1K | — | — | — | — | 532.3K | 0.00% | ↗ |
| 24 | 2019 | Antony A. Riley Chief Financial Officer | 141.7K | — | — | 519.2K | — | — | 660.8K | 78.56% | ↗ |
| 25 | 2019 | Krish S. Krishnan Chair and Chief Executive Officer | 365.7K | 254.2K | — | — | — | 11.2K | 631.1K | 0.00% | ↗ |
| 26 | 2019 | Suma M. Krishnan President, R&D | 305.6K | 140.1K | — | — | — | 11.2K | 456.9K | 0.00% | ↗ |
| 27 | 2019 | Krish S. Krishnan Chairman and Chief Executive Officer | 365.7K | — | — | — | — | — | 365.7K | 0.00% | ↗ |
| 28 | 2019 | Suma M. Krishnan Chief Operating Officer | 305.6K | — | — | — | — | — | 305.6K | 0.00% | ↗ |
| 29 | 2019 | Pooja Agarwal Senior Vice President, Product Development | 209.6K | 50.0K | — | — | — | — | 259.6K | 0.00% | ↗ |
| 30 | 2018 | Krish S. Krishnan Chairman and Chief Executive Officer | 200.0K | 235.0K | 270.0K | — | — | — | 705.0K | 38.30% | ↗ |
| 31 | 2018 | Suma M. Krishnan Chief Operating Officer | 200.0K | 128.5K | 167.0K | — | — | — | 495.4K | 33.71% | ↗ |
| 32 | 2018 | Pooja Agarwal Senior Vice President, Product Development | 189.9K | 40.0K | — | 211.0K | — | — | 441.0K | 47.85% | ↗ |
| 33 | 2018 | Pooja Agarwal Vice President, Product Development | 189.9K | 40.0K | — | 211.0K | — | — | 441.0K | 47.85% | ↗ |
| 34 | 2018 | Antony A. Riley Chief Financial Officer | 103.6K | — | — | 174.6K | — | — | 278.2K | 62.77% | ↗ |
| 35 | 2017 | Pooja Agarwal Vice President, Product Development | 110.0K | 35.0K | — | 61.4K | — | — | 206.4K | 29.74% | ↗ |
| 36 | 2017 | Suma M. Krishnan Chief Operating Officer | 79.4K | — | — | — | — | — | 79.4K | 0.00% | ↗ |
| 37 | 2017 | Krish S. Krishnan Chairman and Chief Executive Officer | 69.4K | — | — | — | — | — | 69.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Krish S. Krishnan | Founder, Chairman, President & Chief Executive Officer | 2M | male |
| Suma Krishnan | Founder, President of R&D and Director | 1M | female |
| Kathryn A. Romano | Executive Vice President & Chief Accounting Officer | 674.8K | female |
| John Karakkal | Vice President of North American Sales & Marketing | — | male |
| John Thomas | EVP, General Counsel & Corporate Secretary | — | male |
| Josh Suskin | Senior Director & Head of US Human Resources | — | male |
| Laurent Goux | Executive VP & Head of International | — | male |
| Stephane Paquette | Senior Vice President of Corporate Development | — | — |
| Christine Wilson | Senior VP & Head of US Commercial | — | female |
| Trevor Parry | Senior Vice President of Product Development | — | male |
| David Chien | Senior Vice President of Clinical Development | — | male |
| David Sweet | Director of Clinical Development | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2022-12-12 | 2023-01-20 | Christopher L. Jacobs | NY27 | — | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KRYS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
